Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice

Journal of Clinical Investigation

Volumn 101, Issue 6, 1998, Pages 1342-1353

  Lei, Xue Feng ^a   Ohkawara, Yuichi ^a   Stämpfli, Martin R ^a   Mastruzzo, Claudio ^a   Marr, Robert A ^a   Snider, Denis ^a   Xing, Zhou ^a   Jordana, Manel ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Airways inflammation; CD40; CD40L; IL 5, IL 4; TNF

Indexed keywords

ANTIGEN; CD40 ANTIGEN; GLYCOPROTEIN GP 39; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; AIRWAY; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; GENE OVEREXPRESSION; GENE TRANSFER; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SENSITIZATION;

EID: 0032521148     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1662     Document Type: Article

References (41)

1. Bradley, B.L., M. Azzawi, M. Jacobson, B. Assoufi, J.V. Collins, A.M. Irani, L.B. Schwartz, S.R. Durham, P.K. Jeffery, and A.B. Kay. 1991. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J. Allergy Clin. Immunol. 88: 661-674.
2. Corrigan, C.J., and A.B. Kay. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today. 13:501-507.
3. Waserman, S., R. Olivenstein, P. Renzi, L.J. Xu, and J.G. Martin. 1992. The relationship between late asthmatic responses and antigen-specific immunoglobulin. J. Allergy Clin. Immunol. 90:661-669.
4. Robinson, D.S., Q. Hamid, S. Ying, A. Tricopoulos, J. Barkans, A.M. Bentley, C. Corrigan, S.R. Durham, and A.B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
5. Zweiman, B. 1993. The late-phase reaction: role of IgE, its receptor and cytokines. Curr. Opin. Immunol. 5:950-955.
6. Ohkawara, Y., X.F. Lei, M.R. Stämpfli, J.S. Marshall, Z. Xing, and M. Jordana. 1997. Cytokine and eosinophil responses in the lung, peripheral blood and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am. J. Respir. Cell Mol. Biol. 16:510-520.
7. Kung, T.T., H. Jones, G.K., Adams III, S.P. Umland, W. Kreutner, R.W. Egan, R.W. Chapman, and A.S. Watnick. 1994. Characterization of a murine model of allergic pulmonary inflammation. Int. Arch. Allergy Immunol. 105:83-90.
8. Kennedy, J.D., C.A. Hatfield, S.F. Fidler, G.E. Winterrowd, J.V. Haas, J.E. Chin, and I.M. Richards. 1995. Phenotypic characterization of T lymphocytes emigrating into lung tissue and the airway lumen after antigen inhalation in sensitized mice. Am. J. Respir. Cell Mol. Biol. 12:613-623.
9. Lack, G., A. Oshiba, K.L. Bradley, J.E. Loader, D. Amran, G.L. Larsen, and E.W. Gelfand. 1995. Transfer of immediate hypersensitivity and airway hyperresponsiveness by IgE-positive B cells. Am. J. Respir. Crit. Care Med. 152: 1765-1773.
10. Gavett, S.H., X. Chen, F. Finkelman, and M. Wills-Karp. 1994. Depletion of murine CD41 T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10:587-593.
11. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, C. van Kooten, Y.J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
12. Jabara, H.H., S.M. Fu, R.S. Geha, and D. Vercelli. 1990. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172: 1861-1864.
13. Grewal, I.S., and R.A. Flavell. 1996. A central role of CD40 ligand in the regulation of CD41 T-cell response. Immunol. Today. 17:410-414.
14. Hollenbaugh, D., H.D. Ochs, R.J. Noelle, J.A. Ledbetter, and A. Aruffo. 1994. The role of CD40 and its ligand in the regulation of the immune response. Immunol. Rev. 138:23-37.
15. Noelle, R.J., J.A. Ledbetter and A. Aruffo. 1992. CD40 and its ligand, and essential ligand-receptor pair for thymus-dependent c-cell activation. Immunol. Today. 13:431-433.
16. Ohkawara, Y., K.G. Lim, Z. Xing, M. Glibetic, K. Nakano, J. Dolovich, K. Croitoru, P.F. Weller, and M. Jordana. 1996. CD40 expression by human peripheral blood eosinophils. J. Clin. Invest. 97:1761-1766.
17. Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kishimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity. 4:275-281.
18. Campbell, K.A., P.J. Ovendale, M.K. Kennedy, W.C. Fanslow, S.G. Reed, and C.R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity. 4:283-289.
19. Soong, L, J.C. Xu, I.S. Grewal, P. Kima, J. Sun, B.J. Longley, N.H. Ruddle, D. McMahon-Pratt, and R.A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity. 4:263-273.
20. Snider, D.P., J.S. Marshall, M.H. Perdue, and H. Liang. 1994. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J. Immunol. 153:647-657.
21. Addison, C.L., J. Gauldie, W.J. Muller, and F.L. Graham. 1995. An adenoviral vector expressing Interleukin-4 modulates tumorigenicity and induces regression in a murine breast cancer model. Int. J. Oncol. 7:1253-1260.
22. Marr, R.A., C.L. Addison, D. Snider, W.J. Muller, J. Gauldie, and F.L. Graham. 1997. Tumor immunotherapy using an adenoviral vector expressing a membrane bound mutant of murine TNFα. Gene Ther. 4:1181-1188.
23. Bett, A.J., W. Haddara, L. Prevec, and F.L. Graham. 1994. An efficient and flexible system for construction of adenovirus with insertion of deletion in early regions 1 and 3. Proc. Natl. Acad. Sci. USA. 91:8802-8806.
24. Nonaka, M., R. Nonaka, K. Woolley, E. Adelroth, K. Miura, Y. Ohkawara, M. Glibetic, K. Nakano, P. O'Byrne, J. Dolovich, and M. Jordana. 1995. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. J. Immunol. 155:3234-3244.
25. Gonzalo, J.A., C.M. Lloyd, L. Kremer, E. Finger, C. Martinez-A., M.H. Siegelman, M. Cybulsky, and J.C. Gutierrez-Ramos. 1996. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines and adhesion receptors. J. Clin. Invest. 10:2332-2345.
26. Renshaw, B., W.C. Fanslow, R.J. Armitage, K.A. Campbell, D. Liggit, B. Wright, B. Davison, and C.R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889-1900.
27. Xu, J., T.M Foy, J.D. Laman, E.A. Elliot, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
28. Hogan, S.P., A. Mould, H. Kikutani, A.J. Ramsay, and P.S. Foster. 1997. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J. Clin. Invest. 99:1329-1339.
29. Foster, P., S.P. Hogan, A.J. Ramsay, K.I. Matthaei, and I.G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity. and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
30. Kung, T.T., D.M. Stelts, J.A. Zurcher, G.K. Adams III, R.W. Egan, W. Kreutner, A.S. Watnick, H. Jones, and R.W. Chapman. 1995. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am. J. Respir. Cell. Mol. Biol. 13: 360-365.
31. Nakajima, H., I. Iwamoto, S. Tomoe, R. Matsumura, H. Tomioka, K. Takatsu, and S. Yoshida. 1992. CD41 T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am. Rev. Respir. Dis. 146:374-377.
32. Ledemarco, M.F., J.L. Barks, and D.C. Dean. 1995. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNFα in cultured endothelial cells. J. Clin. Invest. 95:264-271.
33. Oxenius, A., K.A. Campbell, C.R. Maliszewski, T. Kishimoto, H. Kikutani, H. Hengartner, R.M. Zinkernagel, and M.F. Bachmann. 1996. CD40-CD40 ligand interactions are critical in T-B cooperation but not other anti-viral CD41 T cell functions. J. Exp. Med. 183:2209-2218.
34. Yang, Y., and J.M. Wilson. 1996. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science. 273:1862-1864.
35. Garlisi, C.G., A. Falcone, M.M. Billah, R.W. Egan, and S.P. Umland. 1996. T cells are the predominant source of interleukin-5 but not interleukin-4 mRNA expression in the lungs of antigen-challenged mice. Am. J. Respir. Cell. Mol. Biol. 15:420-427.
36. Gordon, J.R. and S.J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNFα/Cachectin. Nature. 346:274-276.
37. Brown, M.A., J.H. Pierce, C.J. Watson, J. Falco, J.N. Ihle, and W.E. Paul. 1987. B cell stimulatory factor-/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell. 50:809-818.
38. Bradding, P., P.H. Feather, R. Howarth, J.A. Mueller, K. Roberts, J.P.A. Britten, T.C. Bews, Y. Hunt, C.H. Okayama, et al. 1992. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176:1381-1389.
39. Bradding, P., J.A. Roberts, K.M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C.H. Heusser, P.H. Howarth, and S.T. Holgate. 1994. Interleukin-4, -5, and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10:471-480.
40. Bradding, P., R. Mediwake, I.H. Feather, J. Madden, M.K. Church, S.T. Holgate, and P.H. Howarth. 1995. TNFα is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin. Exp. Allergy. 25:406-415.
41. Kozarsky, K.F., and J.M. Wilson. 1993. Gene therapy: adenovirus vectors. Curr. Opin. Genet. Dev. 3:499-503.